Last updated on November 2017

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).


Brief description of study

A Phase III, randomized, double-blind, placebo-controlled trial in patients with Ankylosing Spondylitis (AS).

Detailed Study Description

24-Week trial comparing treatment with Study Medicine vs. placebo.

Patient Inclusion Criteria:

  • Age >/= 18
  • Diagnosis of definite AS
  • Active AS
  • Inadequate response to treatment.

Patient Exclusion Criteria:

  • Major Surgery within 8 weeks prior to screening
  • Inflammatory Disease other than AS
  • Treatment with Investigational Medication within 4 weeks
  • Hepatitis B, C, or HIV

Clinical Study Identifier: TX981

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Suzi DeFiesta

CSI Research Inc
Alpharetta, GA USA
  Connect »